Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Maria Isabel
Maria Isabel Arroyo Villan, Tarragona ES
| Patent application number | Description | Published |
|---|---|---|
| 20100075079 | OZONE RESISTANT COMPOSITIONS AND ARTICLES - The invention relates to a composition comprising a propylene-based interpolymer and a saturated compound selected from the group consisting of aliphatic amides, hydrocarbon waxes, hydrocarbon oils, fluorinated hydrocarbons, and siloxanes, and wherein the propylene-based interpolymer comprises (a) greater than 50 mole percent propylene, based on the total moles of polymerizable monomers, and (b) ethylene, or ethylene and more unsaturated comonomers, or one or more unsaturated comonomers, and wherein the propylene-based interpolymer has at least one of the following properties: (i) 13C NMR peaks corresponding to a regio-error at about 14.6 and about 15.7 ppm, the peaks of about equal intensity, and (ii) a DSC curve with a Tme that remains essentially the same, and a TMax that decreases as the amount of comonomer in the interpolymer is increased. The invention also provides for articles, such as films, comprising at least one component formed from an inventive composition, and for methods of making the same. | 03-25-2010 |
| 20100291344 | COATED SUBSTRATES AND PACKAGES PREPARED THEREFROM - The invention relates to a perforated coated substrate comprising at least the following: i) a first layer, ii) a second layer, and iii) a woven and/or nonwoven web; and wherein the second layer has a lower softening and/or melting temperature, as compared with the respective softening and/or melting temperatures of the first layer, and the respective softening and/or melting temperatures of the web; and wherein the layers of the coated substrate have perforations with a common center. | 11-18-2010 |
| 20110097564 | FILMS, ARTICLES PREPARED THEREFROM, AND METHODS OF MAKING THE SAME - The invention provides a film comprising at least three layers, one inner layer adjacent to two outer layers, and wherein at least one inner layer is formed from a composition comprising an ethylene-based polymer with a density greater than, or equal to, 0.945 g/cc or a cyclic olefin copolymer; and wherein each outer layer is, independently, formed from a composition comprising a propylene-based polymer; and wherein the at least one inner layer is less than, or equal to, 25 percent of the total film thickness. | 04-28-2011 |
Maria Isabel Barriguete Díez, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20120023942 | METHOD FOR INCREASING THE NET ELECTRIC POWER OF SOLAR THERMAL POWER STATIONS - The present invention allows increasing the net electric power supplied to the network by the solar thermal power plants of the cylindrical parabolic collector type by using the solar field in a more efficient manner, generating steam to drive the main ancillaries by means of steam turbines (turbo pumps), reducing electric consumption of the ancillary services and therefore increasing the net electric power of the plant. | 02-02-2012 |
Maria Isabel Carrizales, New York, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110125677 | Decorated Products - Decorated products, such as toothbrushes, of substantially the same type and having substantially the same features (preferably functional features) except for a decorative element. The decorative element on each product is selected from a plurality of different decorative elements such that the products may be visually or aesthetically differentiated from one another by the differences in the decorative element associated therewith, while otherwise having the same functional characteristics. An exemplary embodiment is sleeved adult toothbrushes, the sleeves each having one of a variety of designs, the set of available designs including designs of different categories to appeal to different consumer bases (e.g., different ages, genders, styles, etc.) or to signal a time period for use of the product (e.g., a variety of designs for each of the four seasons to signal changing the toothbrush each season). Preferably, the products are decorated with a design selected from more than one category of designs, at least two of which categories include more than one design. The designs may be changed for the product line on a regular or semi-regular basis to refresh the appearance of the products. | 05-26-2011 |
Maria Isabel Clemente Mayoral, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20100034789 | Novel carbosilane dendrimers, preparation method thereof and use of same - Novel carbosilane dendrimers, their preparation and their uses. The dendrimers of the invention have secondary, tertiary and quaternary amino groups at their branch ends. Their possible uses include vehicles for carrying anionic-charged molecules in the blood, such as nucleic acids, among them ODN and RNAi, and other anionic drugs with which they have the capacity of interacting, protecting them from interaction with plasma protein and/or increasing their penetration rate in target cells. In the cases where the bond is long-lasting, the dendrimers of the invention can be used to fix anionic molecules to surfaces. Their uses also include their administration as active ingredients to prevent or treat diseases caused by micro-organisms with whose structure and/or life cycle they interfere. | 02-11-2010 |
Maria Isabel Crespo Crespo, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20090042933 | Derivatives of 4-(2-amino -1-hydroxyethyl)phenol as agonists of the Beta2 adrenergic receptor - A compound of formula (I) or a pharmaceutically-acceptable salt, solvate or stereoisomer thereof wherein R | 02-12-2009 |
| 20110028442 | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL) PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR - The present disclosure relates to 4-(2-amino-1-hydroxyethyl)phenol derivatives of formula (I) as well as pharmaceutical compositions comprising them, and their use in therapy as agonists of the β2 adrenergic receptor. | 02-03-2011 |
| 20110251165 | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR - The present invention provides a compound of formula (I) wherein: R | 10-13-2011 |
| 20110251166 | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR - The present invention provides a compound of formula (I) wherein: R | 10-13-2011 |
Maria Isabel Gomez-Orellana, New Rochelle, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20080255250 | Compounds and Compositions for Delivering Active Agents - Compounds and compositions for the delivery of active agents are provided. Methods of administration and preparation are provided as well. | 10-16-2008 |
Maria Isabel Jimenez Alonso, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20080248473 | Method and Kit for the Detection of Bacterial Species by Means of Dna Analysis - The present invention relates to the detection and identification of different bacterial species, all of which cause zoonosis, based on DNA analysis. More specifically, the invention provides the primers, probes, genes and genic regions required to apply a method for the simultaneous detection of bacteria and bacterial groups belonging to the genera | 10-09-2008 |
| 20110104696 | KIT FOR DETECTION OF BACTERIAL SPECIES BY MEANS OF DNA ANALYSIS - The present invention relates to the detection and identification of different bacterial species, all of which cause zoonosis, based on DNA analysis. More specifically, the invention provides the primers, probes, genes and genic regions required to apply a method for the simultaneous detection of bacteria and bacterial groups belonging to the genera | 05-05-2011 |
Maria Isabel López Román, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20110219473 | PEDICEL SPECIFIC PROMOTER - The present invention relates to controlling the expression of genes into the pedicel, more specifically in the placentochalaza cells. | 09-08-2011 |
Maria Isabel Lopez-Sanchez, Guadalajara MX
| Patent application number | Description | Published |
|---|---|---|
| 20110098354 | METHOD OF PREPARING A LATANOPROST OPHTHALMIC SOLUTION AND THE RESULTING SOLUTION - A method of solubilizing an analog active agent of the prostaglandin F2α, such as latanoprost, is described and a method of preparing an ophthalmic solution of the solubilized latanoprost for the treatment of distinct ocular ailments. This invention also refers to an ophthalmic aqueous solution resulting from the aforementioned method, which is characterized by its chemical stability at room temperature, its safety, and innocuousness and efficiency in the treatment of the patient. The new ophthalmic aqueous solution is distinguished because its pharmaceutical value is found in the handling of a vehicle of easy access that not only permits the solubility of latanoprost, but also promotes its chemical stability and, a greater tolerance of the patient with its ophthalmic application for the treatment of the patient's ailment. | 04-28-2011 |
| 20110098355 | METHOD OF PREPARING A LATANOPROST OPHTHALMIC SOLUTION AND RESULTING SOLUTION - A method of solubilizing an analog active agent of the prostaglandin F2α, such as latanoprost, is described and a method of preparing an ophthalmic solution of the solubilized latanoprost for the treatment of distinct ocular ailments. This invention also refers to an ophthalmic aqueous solution resulting from the aforementioned method, which is characterized by its chemical stability at room temperature, its safety, and innocuousness and efficiency in the treatment of the patient. The new ophthalmic aqueous solution is distinguished because its pharmaceutical value is found in the handling of a vehicle of easy access that not only permits the solubility of latanoprost, but also promotes its chemical stability and a greater tolerance of the patient with its ophthalmic application for the treatment of the patient's ailment. | 04-28-2011 |
| 20110105605 | METHOD OF PREPARING A LATANOPROST OPHTHALMIC SOLUTION AND THE RESULTING SOLUTION - A method of solubilizing an analog active agent of the prostaglandin F2α, such as latanoprost, is described and a method of preparing an ophthalmic solution of the solubilized latanoprost for the treatment of distinct ocular ailments. This invention also refers to an ophthalmic aqueous solution resulting from the aforementioned method, which is characterized by its chemical stability at room temperature, its safety, and innocuousness and efficiency in the treatment of the patient. The new ophthalmic aqueous solution is distinguished because its pharmaceutical value is found in the handling of a vehicle of easy access that not only permits the solubility of latanoprost, but also promotes its chemical stability and a greater tolerance of the patient with its ophthalmic application for the treatment of the patient's ailment. | 05-05-2011 |
Maria Isabel Lorza, St. Augustine, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20110184448 | LANCING DEVICE - A lancing device formed from a main body and a cap. The main body is configured from a lower housing, an upper housing extending over a portion of the lower housing, and an actuator operatively engaged to the upper and lower housings with the actuator extending along the portion of the lower housing not covered by the upper housing. The upper housing further includes an actuator button, wherein a lancet may be placed within the body such that movement of the actuator from a first position to a second position away from said endcap cocks the lancet for firing, which is achieved by depressing the actuator button. Conveniently, the lancing device is configured for tactile recognition in the palm of a human hand and may preferably be operated one handed and without visual observation. | 07-28-2011 |
Maria Isabel Loza Garcia, Santiago De Compostela ES
| Patent application number | Description | Published |
|---|---|---|
| 20110065138 | Quantitative Method For Detecting Yessotoxins In Fishery Products On Based On The Activation That The Toxin Produces In Cellular Phosphodiesterases And Therapeutic Use Of This Activation - The present invention relates to a quantitative method for detecting yessotoxins in fishery products based on the activation the toxin produces on cellular phosphodiesterases and the therapeutic use of this activation. The cellular target of yessotoxin (YTX) and its analogs is the activation of phosphodiesterases (PDEs). The PDEs-YTX bond produces a measurable signal. The bond can be quantified by means of an affinity biosensor or by fluorescence. The biosensor detects biomolecular interactions and allows determining the presence of YTX due to its interaction with PDEs. The variations in the degradation rate of the fluorescent derivative anthraniloyl-cAMP are determined by means of plate fluorescence. The rate at which the PDEs degrade this molecule increases in the presence of YTX. YTX inhibits immunological activation of mastocytes in rats and induces a cytotoxic effect in human hepatocarcinoma cells, which implies two therapeutic uses of YTXs as an antiallergic and antitumor compound. | 03-17-2011 |
Maria Isabel Moreira Da Costa Franco, Ermesinde PT
| Patent application number | Description | Published |
|---|---|---|
| 20100028489 | PRE-FERMENTED SYMBIOTIC MATRIX BASED ON A CEREAL SUSPENSION WITH ENCAPSULATED PROBIOTICS, MANUFACTURE PROCESS AND CORRESPONDING UTILIZATION - The present invention is about a pre-fermented symbiotic matrix based on a cereal suspension, preferably oat, containing encapsulated probiotics and prebiotics, the manufacturing process and the corresponding utilization. The present invention's object is the development of a cereal symbiotic matrix, preferably from oat, pre-fermented with encapsulated probiotics and free and/or encapsulated prebiotics, with the aim of complementing the actual functional food market and solving problems inherent to the reduced shelf-life period of such foods due to loss of probiotic viability to values below the minimum limits needed in order to promote biological activity. Furthermore, the present invention's object is to improve the fermentative process conditions at different levels, namely fermentation time reduction in order to reduce energy consumption during the process and the risk of contamination reduction as well as promote long term microbial stability maintenance. The pre-fermented symbiotic matrix is designed, in particular, for those cases where intolerance and/or allergy to dairy products occur, yet it is further applicable to the pharmaceutical, cosmetic and preferably food industries, including pet food. | 02-04-2010 |
Maria Isabel Parra-Calvache, Amsterdam NL
| Patent application number | Description | Published |
|---|---|---|
| 20100326133 | METHOD AND APPARATUS FOR COOLING DOWN A CRYOGENIC HEAT EXCHANGER AND METHOD OF LIQUEFYING A HYDROCARBON STREAM - Method and apparatus for cooling down a cryogenic heat exchanger, employing a programmable controller that receives input signals representing sensor signals of one or more controlled variables in a selected process, and produces control signals to control one or more manipulated variables in the selected process. The programmable controller can execute a computer program that comprises a network of at least three modules. The modules in the network are interconnected such a trigger signal received by a second and a third module of the at least three modules corresponds to a communication signal that is generated when the first module of the at least three modules has reached a pre-determined target for that module. | 12-30-2010 |
Maria Isabel Rodriguez Franco, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20100305157 | DERIVATIVES OF DICARBOXYLIC AMINO ACIDS AND THEIR APPLICATION IN THE TREATMENT OF NEURODEGENERATIVE DISEASES - Products of a general formula (I) and their use in the manufacture of medicines useful for the treatment of neurodegenerative diseases such as Alzheimer's disease or, in general, any disease or pathology produced by alterations of biological functions that can be treated or therapeutically modified by these products. | 12-02-2010 |
Maria Isabel Rozas Hernando, Dublin IE
| Patent application number | Description | Published |
|---|---|---|
| 20100160332 | a2-Adrenoceptor Ligands - The adrenergic receptors or adrenoceptors are a family of G-protein coupled receptors split into α and β subclasses. The adrenoceptors have important roles in regulating a myriad of physiological conditions and their malfunction has been implicated in the pathophysiology of a number of diseases. Disclosed herein are a series of novel compounds which are ligands of the alpha2-adrenoceptor (α | 06-24-2010 |
| 20100331384 | GUANIDINE BASED COMPOUNDS - The adrenergic receptors or adrenoceptors are a family of G-protein coupled receptors split into α and β subclasses. The adrenoceptors have important roles in regulating a myriad of physiological conditions and their malfunction has been implicated in the pathophysiology of a number of diseases. Disclosed herein are a series of novel guanidine and 2-aminoimidazoline compounds which are ligands of the alpha2-adrenoceptor (α2-ARs) subclass of adrenergic receptors. The invention also provides for pharmaceutical compositions comprising the novel compounds. The compounds are suitable for use in the manufacture of medicaments for the treatment of α2-ARs associated disorders, such as depression, schizophrenia, glaucoma and analgesia. | 12-30-2010 |
Maria Isabel Sanchez Zarzoso, Salamanca ES
| Patent application number | Description | Published |
|---|---|---|
| 20090208610 | PIZZA - The invention relates to an improved pizza in which a dough grid arises from its dough base, which grid is made of the same dough and completely covers the surface of the pizza occupied by the components, preventing the latter from being separated therefrom. | 08-20-2009 |
Maria Isabel Santacruz, Leicestershire GB
| Patent application number | Description | Published |
|---|---|---|
| 20090294357 | Method for Concentrating Nanosuspensions - A method for concentrating a nanosuspension including nanopowder particles suspended in a liquid includes reducing the liquid content of the nanosuspension and controlling the dispersion of the nanopowder particles in the liquid. | 12-03-2009 |
Maria Isabel Tamargo, Philadelphia, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110230566 | PERFLUOROCARBON EYE CREAM FORMULATIONS - Disclosed are perfluorocarbon compositions for cosmetic applications, in particular, for application to the periocular skin, and methods for using the same. | 09-22-2011 |